| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | G04BE04 |
| UNII: | 2Y49VWD90Q |
| InChI Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26N2O3 |
| Molecular Weight | 354.45 |
| AlogP | 2.65 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 65.56 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 26.0 |
| Primary Target | |
|---|---|
| α2A-adrenoceptor | |
| α2B-adrenoceptor | |
| α2C-adrenoceptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Erectile Dysfunction | 4 | D007172 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Hypotension, Orthostatic | 1 | D007024 | ClinicalTrials |
| Marijuana Abuse | 1 | D002189 | ClinicalTrials |
| Orthostatic Intolerance | 1 | D054971 | ClinicalTrials |
| Parkinson Disease | 0 | D010300 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 146-48-5 |
| ChEBI | 10093 |
| ChEMBL | CHEMBL15245 |
| DrugBank | DB01392 |
| DrugCentral | 3659 |
| EPA CompTox | DTXSID9040130 |
| FDA SRS | 2Y49VWD90Q |
| Human Metabolome Database | HMDB0015464 |
| Guide to Pharmacology | 102 |
| KEGG | C09256 |
| PharmGKB | PA451946 |
| PubChem | 8969 |
| SureChEMBL | SCHEMBL33954 |
| ZINC | ZINC000003860825 |